<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08800259430311</udiDi>
    <basicUdiDi>B-08800259430311</basicUdiDi>
    <tradeName>Staris AQUARIUS HYDRO</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPBN-31BC</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:33.240Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430304</udiDi>
    <basicUdiDi>B-08800259430304</basicUdiDi>
    <tradeName>Staris AQUARIUS HYDRO</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPBN-31</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:32.052Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430298</udiDi>
    <basicUdiDi>B-08800259430298</basicUdiDi>
    <tradeName>Staris PISCES LIGHT</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPLN-30BC</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:30.847Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430281</udiDi>
    <basicUdiDi>B-08800259430281</basicUdiDi>
    <tradeName>Staris ARIES DEEP</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPLN-27BC</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:24.844Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430274</udiDi>
    <basicUdiDi>B-08800259430274</basicUdiDi>
    <tradeName>Staris TAURUS VOL</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPLN-60BC</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:23.739Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430267</udiDi>
    <basicUdiDi>B-08800259430267</basicUdiDi>
    <tradeName>HyalDew lift</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPBN-31BC</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:21.253Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430250</udiDi>
    <basicUdiDi>B-08800259430250</basicUdiDi>
    <tradeName>HyalDew lift</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPBN-31</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:34:20.054Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800077300094</udiDi>
    <basicUdiDi>B-08800077300094</basicUdiDi>
    <tradeName>NEOME</tradeName>
    <deviceName></deviceName>
    <manufacturerName>DEXLEVO INC.</manufacturerName>
    <manufacturerSrn>KR-MF-000012649</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DLMR</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:39.173Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800077300087</udiDi>
    <basicUdiDi>B-08800077300087</basicUdiDi>
    <tradeName>NEOME</tradeName>
    <deviceName>NEOME</deviceName>
    <manufacturerName>DEXLEVO INC.</manufacturerName>
    <manufacturerSrn>KR-MF-000012649</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DLMR</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:37.975Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800077300070</udiDi>
    <basicUdiDi>B-08800077300070</basicUdiDi>
    <tradeName>BELLUXI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>DEXLEVO INC.</manufacturerName>
    <manufacturerSrn>KR-MF-000012649</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DLMR</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:36.865Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800077300063</udiDi>
    <basicUdiDi>B-08800077300063</basicUdiDi>
    <tradeName>BELLUXI</tradeName>
    <deviceName>BELLUXI</deviceName>
    <manufacturerName>DEXLEVO INC.</manufacturerName>
    <manufacturerSrn>KR-MF-000012649</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DLMR</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:34.383Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800077300025</udiDi>
    <basicUdiDi>B-08800077300025</basicUdiDi>
    <tradeName>GOURI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>DEXLEVO INC.</manufacturerName>
    <manufacturerSrn>KR-MF-000012649</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DLMR</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:27.155Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800077300001</udiDi>
    <basicUdiDi>B-08800077300001</basicUdiDi>
    <tradeName>GOURI</tradeName>
    <deviceName>GOURI</deviceName>
    <manufacturerName>DEXLEVO INC.</manufacturerName>
    <manufacturerSrn>KR-MF-000012649</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DLMR</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:25.982Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910182</udiDi>
    <basicUdiDi>B-08800065910182</basicUdiDi>
    <tradeName>08800065910182</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>REJUfeel Ultra Plus</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:05.545Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910175</udiDi>
    <basicUdiDi>B-08800065910175</basicUdiDi>
    <tradeName>08800065910175</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>REJUfeel Deep Plus</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:04.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910168</udiDi>
    <basicUdiDi>B-08800065910168</basicUdiDi>
    <tradeName>08800065910168</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>REJUfeel Light Plus</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:32:01.967Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910151</udiDi>
    <basicUdiDi>B-08800065910151</basicUdiDi>
    <tradeName>08800065910151</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Gioluxe Duo Ultra</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:54.740Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910144</udiDi>
    <basicUdiDi>B-08800065910144</basicUdiDi>
    <tradeName>08800065910144</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Gioluxe Duo Deep</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:53.539Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065910137</udiDi>
    <basicUdiDi>B-08800065910137</basicUdiDi>
    <tradeName>08800065910137</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Gioluxe Duo Light</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:52.360Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800065900268</udiDi>
    <basicUdiDi>B-08800065900268</basicUdiDi>
    <tradeName>08800065900268</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid with Lidocaine and Polynucleotide</deviceName>
    <manufacturerName>BMI Korea Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000035107</manufacturerSrn>
    <authorisedRepresentativeName>JaviTech e.K.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005875</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>Prodermis PROSCULPT Deep</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:31:51.147Z</lastUpdated>
  </row>
</eudamedExport>